Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT01205893
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 104 participants
- Sponsor
- Registry
-
NCT01205893
-
- Other papers using this trial's data
- A novel method to interpret early phase trials shows how the narrowing of the coronary sinus concordantly improves symptoms, functional status and quality of life in refractory angina
- Efficacy of a device to narrow the coronary sinus in refractory angina
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, Canada, Denmark, Netherlands, Sweden, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01205893. Randomized; double masking; primary purpose treatment. Start 2010-09 (registry gives no type); primary completion 2013-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Coronary Sinus Reducer for Treatment of Refractory Angina - COSIRA
- Acronym
- COSIRA
- Condition
- Refractory Angina
- Intervention (Device)
- Neovasc Reducer
- Intervention (Device)
- Control
- Lead sponsor
- Shockwave Medical, Inc.
Record details
- Record id
cardio:ct-nct01205893- Content hash
bcb102d73ae70776dee6f80926dbbafb408c82fab9655216dcd6e2dbc077eb0e